Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1971 3
1974 1
1975 2
1976 2
1978 1
1980 1
1981 1
1983 2
1985 1
1986 2
1987 3
1988 3
1989 2
1990 4
1991 9
1992 8
1993 2
1994 3
1995 3
1996 6
1997 5
1998 12
1999 25
2000 7
2001 9
2002 20
2003 18
2004 37
2005 36
2006 35
2007 39
2008 40
2009 41
2010 39
2011 29
2012 42
2013 45
2014 50
2015 58
2016 66
2017 82
2018 78
2019 107
2020 194
2021 171
2022 152
2023 126
2024 60

Text availability

Article attribute

Article type

Publication date

Search Results

993 results

Results by year

Filters applied: Meta-Analysis, Review, Systematic Review, in the last 10 years. Clear all
Page 1
Review of delta-8-tetrahydrocannabinol (delta(8) -THC): Comparative pharmacology with delta(9) -THC.
Tagen M, Klumpers LE. Tagen M, et al. Br J Pharmacol. 2022 Aug;179(15):3915-3933. doi: 10.1111/bph.15865. Epub 2022 Jun 1. Br J Pharmacol. 2022. PMID: 35523678 Free article. Review.
The use of the intoxicating cannabinoid delta-8-tetrahydrocannabinol (delta(8) -THC) has grown rapidly over the last several years. ...
The use of the intoxicating cannabinoid delta-8-tetrahydrocannabinol (delta(8) -THC) has grown rapidly over the last several years. . …
Cannabis sativa: Much more beyond delta(9)-tetrahydrocannabinol.
Alves P, Amaral C, Teixeira N, Correia-da-Silva G. Alves P, et al. Pharmacol Res. 2020 Jul;157:104822. doi: 10.1016/j.phrs.2020.104822. Epub 2020 Apr 23. Pharmacol Res. 2020. PMID: 32335286 Review.
Cannabis is the most used illicit drug worldwide and its medicinal use is under discussion, being regulated in several countries. However, the psychotropic effects of delta(9)-tetrahydrocannabinol (THC), the main psychoactive compound of Cannabis sativa, are of concern. .. …
Cannabis is the most used illicit drug worldwide and its medicinal use is under discussion, being regulated in several countries. However, t …
Cannabidiol and delta8-Tetrahydrocannabinol: Cannabinoids of Rising Interest and Concern.
White RM. White RM. Forensic Sci Rev. 2023 Jan;35(1):27-45. Forensic Sci Rev. 2023. PMID: 36575371 Review.
Although much is known about delta9-tetrahydrocannabinol and its inactive open ring isomer, cannabidiol, far less is known about the effects, metabolism, and pharmacodynamics of delta9-tetrahydrocannabinol's double-bond isomer, delta8-tetrahydrocannabinol. Wi …
Although much is known about delta9-tetrahydrocannabinol and its inactive open ring isomer, cannabidiol, far less is known about the …
Tetrahydrocannabinol and dopamine D1 receptor.
Lee J. Lee J. Front Neurosci. 2024 Feb 14;18:1360205. doi: 10.3389/fnins.2024.1360205. eCollection 2024. Front Neurosci. 2024. PMID: 38419666 Free PMC article. Review.
Delta-8 tetrahydrocannabinol: a scoping review and commentary.
LoParco CR, Rossheim ME, Walters ST, Zhou Z, Olsson S, Sussman SY. LoParco CR, et al. Addiction. 2023 Jun;118(6):1011-1028. doi: 10.1111/add.16142. Epub 2023 Feb 13. Addiction. 2023. PMID: 36710464 Review.
BACKGROUND AND AIMS: Delta-8 tetrahydrocannabinol (THC) is a psychoactive substance from the Cannabis plant that has been rising in popularity in the United States since the 2018 US Farm Bill implicitly legalized it. ...
BACKGROUND AND AIMS: Delta-8 tetrahydrocannabinol (THC) is a psychoactive substance from the Cannabis plant that has been rising in p …
Drug Interactions of Tetrahydrocannabinol and Cannabidiol in Cannabinoid Drugs.
Herdegen T, Cascorbi I. Herdegen T, et al. Dtsch Arztebl Int. 2023 Dec 8;120(49):833-840. doi: 10.3238/arztebl.m2023.0223. Dtsch Arztebl Int. 2023. PMID: 37874128 Free PMC article. Review.
BACKGROUND: Cannabinoid drugs containing tetrahydrocannabinol (THC), or its structural analogues, as monotherapeutic agents or as extracts or botanical preparations with or without cannabidiol (CBD) are often prescribed to multimorbid patients who are taking multiple drugs …
BACKGROUND: Cannabinoid drugs containing tetrahydrocannabinol (THC), or its structural analogues, as monotherapeutic agents or as ext …
Cannabis, cannabidiol and tetrahydrocannabinol in sport: an overview.
Kennedy M. Kennedy M. Intern Med J. 2022 Sep;52(9):1471-1477. doi: 10.1111/imj.15724. Epub 2022 Aug 13. Intern Med J. 2022. PMID: 35191178 Review.
This includes commercial sponsorship of sporting events and highlights the need for accurate information to be readily available to athletes and their advisers. This narrative review confirms that CBD and tetrahydrocannabinol (THC) do not enhance performance. CBD possesses …
This includes commercial sponsorship of sporting events and highlights the need for accurate information to be readily available to athletes …
Oral Administration of Cannabis and delta-9-tetrahydrocannabinol (THC) Preparations: A Systematic Review.
Poyatos L, Pérez-Acevedo AP, Papaseit E, Pérez-Mañá C, Martin S, Hladun O, Siles A, Torrens M, Busardo FP, Farré M. Poyatos L, et al. Medicina (Kaunas). 2020 Jun 23;56(6):309. doi: 10.3390/medicina56060309. Medicina (Kaunas). 2020. PMID: 32585912 Free PMC article.
From a therapeutic perspective, oral cannabis containing delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) is a promising route of administration but there is still little information about its pharmacokinetics (PK) effects in humans. ...
From a therapeutic perspective, oral cannabis containing delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) is a promising rout …
Tetrahydrocannabinol and cannabidiol medicines for chronic pain and mental health conditions.
Henson JD, Vitetta L, Hall S. Henson JD, et al. Inflammopharmacology. 2022 Aug;30(4):1167-1178. doi: 10.1007/s10787-022-01020-z. Epub 2022 Jul 7. Inflammopharmacology. 2022. PMID: 35796920 Free PMC article. Review.
Combination tetrahydrocannabinol (THC)/cannabidiol (CBD) medicines or CBD-only medicines are prospective treatments for chronic pain, stress, anxiety, depression, and insomnia. ...
Combination tetrahydrocannabinol (THC)/cannabidiol (CBD) medicines or CBD-only medicines are prospective treatments for chronic pain, …
993 results